Progestin permeation through polymer membrane V: Progesterone release from monolithic hydrogel devices. 1981

S Z Song, and J R Cardinal, and S H Kim, and S W Kim

Progesterone release from monolithic devices prepared from various copolymers of poly(hydroxyethyl methacrylate) and poly(methoxyethoxyethyl methacrylate) or poly(methoxyethyl methacrylate) was examined. In general, plots of the fraction of drug released versus (time)1/2 were linear during the early stages of drug release. This behavior is similar to that found for drugs released from hydrophobic polymers such as polydimethyl siloxane. However, for some release curves using the hydrogels, a breakpoint appeared during the early stages of drug release. These breakpoints were due to the effects of water absorption by these polymers. From analyses of permeability coefficients, it was demonstrated that release rates also were dependent on the initial drug load and the equilibrium water content of the polymer. These conclusions were verified from cross-membrane diffusion studies on films depleted of their initial drug load. In conjunction with this work, the aqueous solubility of progesterone was determined by several methods; an average value of 38 micrograms/ml at 23 degrees was obtained.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D011102 Polyhydroxyethyl Methacrylate A biocompatible, hydrophilic, inert gel that is permeable to tissue fluids. It is used as an embedding medium for microscopy, as a coating for implants and prostheses, for contact lenses, as microspheres in adsorption research, etc. Glycol Methacrylate Gel,Hydroxymethacrylate Gel,PHEMA,Poly-Hema,Polyglycol Methacrylate,Gel, Glycol Methacrylate,Gel, Hydroxymethacrylate,Methacrylate Gel, Glycol,Methacrylate, Polyglycol,Methacrylate, Polyhydroxyethyl,Poly Hema
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer

Related Publications

S Z Song, and J R Cardinal, and S H Kim, and S W Kim
June 1979, Journal of pharmaceutical sciences,
S Z Song, and J R Cardinal, and S H Kim, and S W Kim
October 1978, Journal of pharmaceutical sciences,
S Z Song, and J R Cardinal, and S H Kim, and S W Kim
September 1990, Journal of biomedical materials research,
S Z Song, and J R Cardinal, and S H Kim, and S W Kim
October 1978, Journal of pharmaceutical sciences,
S Z Song, and J R Cardinal, and S H Kim, and S W Kim
April 1988, Il Farmaco; edizione pratica,
S Z Song, and J R Cardinal, and S H Kim, and S W Kim
October 2009, International journal of pharmaceutics,
S Z Song, and J R Cardinal, and S H Kim, and S W Kim
November 1968, The Journal of pharmacy and pharmacology,
S Z Song, and J R Cardinal, and S H Kim, and S W Kim
January 2001, Drug development and industrial pharmacy,
S Z Song, and J R Cardinal, and S H Kim, and S W Kim
January 2007, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques,
S Z Song, and J R Cardinal, and S H Kim, and S W Kim
January 2000, ASAIO journal (American Society for Artificial Internal Organs : 1992),
Copied contents to your clipboard!